Current state of NK cell-mediated immunotherapy in chronic lymphocytic leukemia

Chronic lymphocytic leukemia (CLL) has become one of the most common hematological diseases in western countries, with an annual incidence of 42/100,000. Conventional chemotherapy and targeted therapeutic drugs showed limitations in prognosis or in efficiency in high-risk patients. Immunotherapy rep...

Full description

Bibliographic Details

Published in:	Frontiers in Oncology
Main Authors:	Zong-Han Wang, Wei Li, Hao Dong, Fujun Han
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-01-01
Subjects:	CLL NK cells immunotherapy receptors anti-tumor activity
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2022.1077436/full